Related Experiment Videos
[Cutaneous CD8+ squamous T-cell bullous lymphoma]
I Héliot-Hosten1, J Versapuech, B Vergier
1Unité de Dermatologie Cancérologie, Hôpital Saint-André, CHU Bordeaux, Université Bordeaux 2 Victor Ségalen, Bordeaux. isabelle.heliot@chu-bordeaux.fr
Annales De Dermatologie Et De Venereologie
|May 12, 2005
Summary
Bullous cutaneous T-cell lymphomas can indicate a rare CD8+ variant. This aggressive lymphoma presents with polymorphic lesions and spongiosis, often resisting standard chemotherapy.
Area of Science:
- Dermatology
- Oncology
- Immunopathology
Background:
- Cutaneous T-cell lymphomas (CTCL) are a group of malignant skin lymphomas.
- Bullous presentations of CTCL are uncommon.
- A distinct subtype, CD8+ CTCL, is characterized by a CD8+ immunophenotype.
Observation:
- This report details a case of cutaneous CD8+ squamous T-cell lymphoma.
- The patient exhibited polymorphic clinical features, including bullous lesions.
- Histopathology revealed a strongly epidermotropic lymphoid infiltrate and spongiosis.
Findings:
- The presence of bullous lesions in CTCL warrants consideration of the CD8+ subtype.
- Spongiosis and a pleomorphic, epidermotropic lymphoid infiltrate are characteristic histological findings.
- Early diagnosis is crucial, as the condition can present with varied lesions and bullae.
Implications:
- Cutaneous CD8+ T-cell lymphoma is an aggressive malignancy with a poor prognosis.
- Standard chemotherapy is often ineffective, highlighting the need for novel therapeutic strategies.
- Recognition of this rare entity is vital for timely diagnosis and management.